Page last updated: 2024-08-26

mci 9038 and Lupus Erythematosus, Systemic

mci 9038 has been researched along with Lupus Erythematosus, Systemic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Athar, U; Gajra, A; Hudson, J; Husain, J; Lynch, J1

Other Studies

1 other study(ies) available for mci 9038 and Lupus Erythematosus, Systemic

ArticleYear
Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia.
    American journal of hematology, 2008, Volume: 83, Issue:3

    Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Cholangiopancreatography, Endoscopic Retrograde; Female; Half-Life; Heparin; Humans; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Middle Aged; Peritoneal Dialysis; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin

2008